Acquisition eliminates all future royalty payment obligations for PH94B and PH10 and expands Vistagen's pipelineSOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--$VTGN #mentalhealth--Vistagen (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals livin...